- Efficacy of Levofloxacin and Rifaximin based Quadruple Therapy in Helicobacter pylori Associated Gastroduodenal Disease: A Double-Blind, Randomized Controlled Trial
-
Choi KH, Chung WC, Lee KM, Paik CN, Kim EJ, Kang BK, Oak JH, Jung SH
- KMID: 1785965
- J Korean Med Sci.
- 2011 Jun;26(6):785-790.
- doi: 10.3346/jkms.2011.26.6.785
The aim of this study was to evaluate the efficacy of levofloxacin and rifaximin based quadruple regimen as first-line treatment for Helicobacter pylori infection. A prospectively randomized, double-blinded, parallel group,... -
- CITED
-
- Close
- SHARE
-
- Close
- Relationship between Helicobacter pylori and rosacea: it may be a myth
-
Herr H, You CH
- KMID: 965878
- J Korean Med Sci.
- 2000 Oct;15(5):551-554.
- doi: 10.3346/jkms.2000.15.5.551
Although it is debatable whether Helicobacter pylori may play a role in the pathogenesis of rosacea, some authors suggested that the treatment of H. pylori might have a beneficial effect.... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of 14 Day OBMT Therapy as a Second-line Treatment for Helicobacter pylori Infection
-
Park SC, Chun HJ, Jung SW, Keum B, Han WS, Choung RS, Kim YS, Jeen YT, Lee HS, Um SH, Lee SW, Choi JH, Kim CD, Ryu HS, Hyun JH
- KMID: 1113356
- Korean J Gastroenterol.
- 2004 Sep;44(3):136-141.
BACKGROUND/AIMS: As a second-line treatment for H. pylori eradication in the case of first-line OAC (omeprazole, amoxicillin, clarithromycin) treatment failure, a minimum of one-week OBMT quadruple therapy composed of... -
- CITED
-
- Close
- SHARE
-
- Close
- Effectiveness of 10 Day-sequential Therapy for Helicobacter pylori Eradication in Korea
-
Choi WH, Park DI, Oh SJ, Baek YH, Hong CH, Hong EJ, Song MJ, Park SK, Park JH, Kim HJ, Cho YK, Sohn CI, Jeon WK, Kim BI
- KMID: 1767527
- Korean J Gastroenterol.
- 2008 May;51(5):280-284.
BACKGROUND/AIMS: Antibiotic resistance and poor compliance are the main causes of Helicobacter pylori (H. pylori) eradication failure. Proton pump inhibitor (PPI)-based triple therapy is the most preferred regimen in clinical... -
- CITED
-
- Close
- SHARE
-
- Close
- Role of Anti-secretory Treatment in Addition to Helicobacter pylori Eradication Triple Therapy in the Treatment of Peptic Ulcer
-
Jung JM, Shim KN, Oh HJ, Na YJ, Jung HS, Jung SA, Yoo K
- KMID: 782957
- Korean J Gastroenterol.
- 2008 Jan;51(1):11-18.
BACKGROUND/AIMS: It is not clear whether the anti-secretory therapy should be continued for symptomatic relief and ulcer healing before or after the eradication of H. pylori in patients with peptic... -
- CITED
-
- Close
- SHARE
-
- Close
- Influence of CYP2C19 Polymorphism and Helicobacter pylori Status on the Antisecretory Effect of Omeprazole in Gastroesophageal Reflux Disease
-
Sohn YH, Lee WS, Park CH, Joo YE, Kim HS, Choi SK, Rew JS, Kim SJ
- KMID: 782759
- Korean J Gastroenterol.
- 2006 Sep;48(3):162-171.
BACKGROUND/AIMS: The acid suppressive effect of omeprazole (OMP) is influenced by the metabolic capacity of gastric acid suppression, which is dependent on CYP2C19 polymorphism. The aim of this study was... -
- CITED
-
- Close
- SHARE
-
- Close
- Extraesophageal Manifestations of Gastroesophageal Reflux Disease
-
Kim GH
- KMID: 783037
- Korean J Gastroenterol.
- 2008 Aug;52(2):69-79.
Gastroesophageal reflux disease (GERD) often presents as typical symptoms such as heartburn or acid regurgitation. However, a subgroup of patients presents a collection of symptoms and signs that are not... -
- CITED
-
- Close
- SHARE
-
- Close
